End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3601 USD | -18.16% | -54.99% | 0.00% |
Apr. 15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
2023 | Transcript : Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 |
Quotes 5-day view
End-of-day quote OTC Markets2024-05-07 | 2024-05-08 | 2024-05-09 | 2024-05-10 | 2024-05-13 | |
---|---|---|---|---|---|
Last | 0.879 $ | 0.78 $ | 0.65 $ | 0.44 $ | 0.3601 $ |
Volume | 5 359 | 1 577 | 2 503 | 23 555 | 41 756 |
Change | +9.87% | -11.26% | -16.67% | -32.31% | -18.16% |
Opening | 0.80 | 0.78 | 0.54 | 0.68 | 0.40 |
High | 0.88 | 0.78 | 0.65 | 0.68 | 0.40 |
Low | 0.75 | 0.78 | 0.54 | 0.40 | 0.30 |
Performance
1 day | -18.16% | ||
1 week | -54.99% | ||
Current month | -48.56% | ||
1 month | -18.16% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-18.16% | -54.99% | - | - | 529K | ||
+1.69% | +6.81% | +5.66% | +23.75% | 111B | ||
+0.32% | +1.91% | +11.23% | +31.25% | 105B | ||
-1.64% | -5.83% | -0.38% | -7.56% | 21.93B | ||
+1.15% | -0.67% | -12.15% | -11.90% | 22.34B | ||
-0.65% | -0.70% | -7.66% | -30.64% | 18.59B | ||
+2.99% | +0.90% | -36.52% | -30.25% | 18.12B | ||
+0.65% | -0.19% | -10.09% | -31.97% | 16.96B | ||
-0.40% | -3.92% | +3.33% | +40.78% | 13.7B | ||
-0.09% | -2.47% | +36.58% | +9.57% | 12.45B | ||
-1.75% | -7.49% | +288.77% | +221.13% | 7.98B | ||
-0.62% | -5.06% | -28.59% | -38.84% | 7.82B | ||
+4.53% | +2.50% | -50.07% | -68.04% | 7.53B | ||
-0.31% | -1.08% | -0.80% | +31.73% | 7.66B | ||
-1.08% | -1.48% | +4.82% | +38.39% | 7.54B | ||
+0.78% | -1.05% | +4.62% | +32.78% | 7.15B | ||
Average | -0.79% | -5.25% | +13.92% | +14.01% | ||
Weighted average by Cap. | +0.69% | +1.48% | +7.32% | +16.14% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
- Stock Market
- Equities
- ACOR.Q Stock
- Quotes Acorda Therapeutics, Inc.